Feasibility and Safety of a Reduced Duration of Therapy of Colony-Stimulating Factor in a Dose-Dense Regimen

Supportive Care in Cancer - Germany
doi 10.1007/s00520-014-2237-9
Full Text
Abstract

Available in full text

Categories
Oncology
Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Granulocyte Colony Stimulating Factor (G-Csf) Induced Splenic Infarction in Breast Cancer Patient Treated With Dose-Dense Chemotherapy Regimen

Case Reports in Oncological Medicine
Oncology
2019English

A Bayesian Meta-Analysis of Prophylactic Granulocyte Colony-Stimulating Factor and Granulocyte-Macrophage Colony-Stimulating Factor in Children With Cancer

American Journal of Epidemiology
Epidemiology
2006English

Clinical Efficacy and Safety of Tevagrastim® (XM02), a Biosimilar Recombinant Human Granulocyte Colony-Stimulating Factor

Biosimilars
2013English

Granulocyte-Colony Stimulating Factor

JAMA - Journal of the American Medical Association
Medicine
2006English

Granulocyte Colony-Stimulating Factor

Reactions Weekly
1991English

Effects of Recombinant Granulocyte Colony-Stimulating Factor and Granulocyte-Macrophage Colony-Stimulating Factor on Platelet Aggregation in Healthy Volunteers

Turkiye Klinikleri Journal of Medical Sciences
Medicine
2015English

A Case of Granulocyte-Colony Stimulating Factor Producing Colon Cancer

Nihon Rinsho Geka Gakkai Zasshi (Journal of Japan Surgical Association)
2014English

Safety of Recombinant Human Granulocyte-Macrophage Colony-Stimulating Factor in Healing Pediatric Severe Burns

Genetics and Molecular Research
MedicineGeneticsMolecular Biology
2015English

Biological Activities of a Human Pluripotent Hemopoietic Colony-Stimulating Factor

Haematology and Blood Transfusion / Hämatologie und Bluttransfusion
1985English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy